Theravance Biopharma has been granted a patent for compounds with neprilysin inhibition activity, including prodrugs. The patent also covers methods of making Compound 6N and pharmaceutical compositions containing these compounds. GlobalData’s report on Theravance Biopharma gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Theravance Biopharma, was a key innovation area identified from patents. Theravance Biopharma's grant share as of April 2024 was 66%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US11919888B2) discloses a method for producing Compound 6N. The method involves a series of steps, including contacting Compound 1 and a compound with a specific structure. The conditions for the process may include ethyl acetate and acetic acid, as outlined in the patent claims.
Furthermore, the method detailed in the patent also involves specific conditions for the process, such as the use of N,N,N',N'-tetramethyl-O-(7-azabenzotriazol-1-yl)uronium hexafluorophosphate and N-ethyl-N-isopropylpropan-2-amine. Additionally, the conditions for another step in the process may include acetonitrile and dioxane. These specific conditions and steps are crucial for the successful production of Compound 6N as outlined in the patent claims.
To know more about GlobalData’s detailed insights on Theravance Biopharma, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
